Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We assessed the association of glycosylated fibronectin (GlyFn) with preeclampsia and its performance in a point-of-care (POC) test.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Obstet. Gynecol.

Title: American journal of obstetrics and gynecology

ISSN (Electronic): 1097-6868

ISSN (Print): 0002-9378

Publication date (Electronic): Jan 2015

Volume: 212

Issue: 1

Affiliations

[1 ] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR; Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, and Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.

[2 ] DiabetOmics Inc, Hillsboro, OR.

[3 ] Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA. Electronic address: gravettm@u.washington.edu.